Our extensive outreach and engagement efforts have generated an enriched pool of 1,600+ patients (and growing) across eight US geographies. Each of these patients has been pre-screened for GLP-1 trials with a confirmed interest in proceeding to formal screening for any new trials.
Ready to supercharge your GLP-1 study enrollment?
Contact Javara today!
Download Javara’s Accelerated Start-up Case Study
Read how our site staff and centralized support teams delivered real, meaningful results for the study sponsor in a recent GLP-1 clinical trial.
Download Now
Javara has proven experience, with our sites being first to enroll patients on a recent GLP-1 global trial.
We have a 90% patient retention rate due to our personalized approach and connecting with patients through their trusted physicians.
Our investigators and staff have been thoroughly trained on the distinctive needs of this unique patient population.